SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001787306-24-000048
Filing Date
2024-04-11
Accepted
2024-04-11 20:30:58
Documents
5
Period of Report
2024-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1712881847.html 3  
1 FORM 3 wk-form3_1712881847.xml 3 2793
2 EX-24 conformedpoafordavidtopp.htm EX-24 4862
3 conformedpoafordavidtopp001.jpg GRAPHIC 261397
4 conformedpoafordavidtopp002.jpg GRAPHIC 37764
5 conformedpoafordavidtopp003.jpg GRAPHIC 34026
  Complete submission text file 0001787306-24-000048.txt   468359
Mailing Address C/O GENERAL ATLANTIC SERVICE COMPANY, LP 55 EAST 52ND STREET, 32ND FLOOR NEW YORK NY 10055
Business Address
Topper David Joseph (Reporting) CIK: 0001740378 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39186 | Film No.: 24839764

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)